课题基金 / 基金详情

The oral and gut microbiome and their derived metabolites in sex differences in amyotrophic lateral sclerosis

The oral and gut microbiome and their derived metabolites in sex differences in amyotrophic lateral sclerosis
肌萎缩侧索硬化症性别差异中的口腔和肠道微生物组及其衍生代谢物
批准号：
464091
负责人：
Pfeffer Gerald
金额：
$0.0万
依托单位：
University of Calgary
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-04-01 至 2026-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=464091&lang=en
关键词：
Amyotrophic Lateral Sclerosis Microbiome Neurodegeneration Neuromuscular Disease

项目摘要

项目成果

Pfeffer Gerald的其他基金

相似基金

相关文献

中文摘要
翻译
肌萎缩侧索硬化症(ALS)是一种神经系统疾病，患者逐渐失去肌肉的功能。这会导致行动不便、自我照顾、言语、吞咽和呼吸等方面的问题。这种疾病恶化很快，通常会导致死亡。
英文摘要
Amyotrophic lateral sclerosis (ALS) is a neurologic disease in which patients gradually lose the use of their muscles. This causes problems with mobility, self-care, speech, swallowing and breathing. The disease worsens quickly and usually leads to death
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the molecular mechanism in hereditary cytoplasmic body myopathy with early respiratory failure: implications for understanding ventilatory failure in muscular dystrophies
Defining the molecular mechanism in hereditary cytoplasmic body myopathy with early respiratory failure: implications for understanding ventilatory failure in muscular dystrophies
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis